Menu

HRSA recently announced that a 340B ADR panel had rejected two hospitals' petition challenging Novo Nordisk's contract pharmacy restrictions.

Fourth 340B Administrative Dispute Resolution Panel Sides with Drug Industry

January 23, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

The latest decision under the federal government’s revamped 340B Administrative Dispute Resolution (ADR) process once again sided with drugmakers, dealing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

GSK Adds 340B Contract Pharmacy Restrictions to Asthma Biologic

House Passes Bipartisan-Backed Spending Bill that Funds HRSA and Health Centers, Targets PBMs